Melatonin enhances the in vitro action of cytochalasin B on globular resistance and osmotic fragility of erythrocytes: A preliminary study

Neuroendocrinology Letters

Volumn 32, Issue 3, 2011, Pages 292-300

  Pacini, Nicola ^a   Ferrari, Anna ^a,b   Menozzi, Mattia ^a,b   Borziani, Fabio ^a,b  

^a Prof Luigi di Bella Private Physiology Laboratory   (Italy)

^b NONE   (Italy)

Author keywords

Cytochalasin B; Cytoskeleton; Erythrocyte; Globular resistance; Lactate dehydrogenase; Malondialdehyde; Melatonin; Membrane deformability; Osmotic fragility; Phospholipids

Indexed keywords

CYTOCHALASIN B; LACTATE DEHYDROGENASE; MALONALDEHYDE; MELATONIN; PHOSPHOLIPID;

ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOSKELETON; ERYTHROCYTE FRAGILITY; HEMOLYSIS; IN VITRO STUDY; NONHUMAN; RAT;

EID: 80052014032     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (71)

1. Akmali M, Ahmadi R, Vessal M (2010) Pre- and post-treatment of streptozocin administered rats with melatonin: effects on some hepatic enzymes of carbohydrate metabolism. Arch Iran Med. 13(2): 105-10.
2. Aldridge DC, Armstrong JJ, Speaks RN, Turner WB (1967) The cytochalasins, a new class of biologically active mould metabolites. Chemical Communications. 26-27.
3. Atlas SJ, Lin S (1978) Dihydrocytochalasin B. Biological effects and binding to 3T3 cells. J Cell Biol. 76(2): 360-70. (Pubitemid 8278979)
4. Atlas SJ, Magargal WW, Lin S (1980) The relationship between high-affinity binding of cytochalasin B to 3T3 cells and inhibition of sugar transport and cell motility. J Recept Res. 1(2): 113-35. (Pubitemid 11207145)
5. Aydogan S, Yerer MB, Yapislar H (2004) In vitro effects of melatonin on the filtrability of erythrocytes in SNP-induced oxidative stress. Clin Hemorheol Microcirc. 30(3-4): 317-22.
6. Beck JS, Jay AW, Saari JT (1972) Effects of cytochalasin B on osmotic fragility and deformability of human erythrocytes. Can J Physiol Pharmacol. 50(7): 684-8.
7. Benítez-King G, Antón-Tay F (1993) Calmodulin mediates melatonin cytoskeletal effects. Experientia. 49(8): 635-41.
8. Benitez-King G, Huerto-Delgadillo L, Antón-Tay F (1993) Binding of 3H-melatonin to calmodulin. Life Sci. 53(3): 201-7.
9. Benítez-King G (2006) Melatonin as a cytoskeletal modulator: implications for cell physiology and disease. J Pineal Res. 40(1): 1-9.
10. Benítez-King G, Soto-Vega E, Ramírez-Rodriguez G (2009) Melatonin modulates microfilament phenotypes in epithelial cells: implications for adhesion and inhibition of cancer cell migration. Histol Histopathol. 24(6): 789-99.
11. Bonder EM, Mooseker MS (1986) Cytochalasin B slows but does not prevent monomer addition at the barbed end of the actin filament. J Cell Biol. 102(1): 282-8. (Pubitemid 16155575)
12. Brenner SL, Korn ED (1979) Substoichiometric concentrations of cytochalasin D inhibit actin polymerization. Additional evidence for an F-actin treadmill. J Biol Chem. 254(20): 9982-5. (Pubitemid 10162017)
13. Brenner SL, Korn ED (1980) The effects of cytochalasins on actin polymerization and actin ATPase provide insights into the mechanism of polymerization. J Biol Chem. 255(3): 841-4. (Pubitemid 10108127)
14. Carrillo-Vico A, Calvo JR, Abreu P etal. (2004) Evidence of melatonin synthesis by human lymphocytes and its physiological significance: possible role as intracrine, autocrine, and/or paracrine substance. Faseb J. 18(3): 537-9.
15. Carrillo-Vico A, Guerrero JM, Lardone PJ, Reiter RJ (2005) A review of the multiple actions of melatonin on the immune system. Endocrine. 27(2): 189-200. (Pubitemid 41558451)
16. Carter SB (1967) Effects of cytochalasins on mammalian cells. Nature. 213(5073): 261-4.
17. Champier J, Claustrat B, Besançon R et al. (1997) Evidence for tryptophan hydroxylase and hydroxy-indol-O-methyl-transferase mRNAs in human blood platelets. Life Sci. 60(24): 2191-7. (Pubitemid 27244401)
18. Conti A, Conconi S, Hertens E ef al. (2000) Evidence for melatonin synthesis in mouse and human bone marrow cells. J Pineal Res. 28(4): 193-202.
19. Di Bella L, Rossi MT, Pellegrino N et al. (1969) Ruolo del sistema abenulo-epifisario nella regolazione del tasso piastrinemico. Boll Soc Ital Biol Sper. Vol. XLV, N.20 bis.
20. Di Bella L, Rossi MT, Gualano L, Scalera G (1979) Effect of the simultaneous action of melatonin and ADP in megakaryocytes in vitro. Boll Soc Ital Biol Sper. 55(5): 389-93. (Pubitemid 10244540)
21. Di Bella L, Rossi MT, Scalera G (1979) Perspectives in pineal functions. Prog Brain Res.52: 475-8.
22. Di Bella L, Rossi MT (1980) Red Blood cells generation and melatonin. International Symposium on melatonin. Bremen, 28-30 September 1980.
23. Di Bella L, Bruschi C, Gualano L (2002) Melatonin effects on megakaryocyte membrane patch-clamp outward K+ current. Med Sci Monit. 8(12): BR527-31.
24. Dikmenoglu N, Ileri E, Seringec N, Ercil D (2008) Melatonin prevents lipid peroxidation in human erythrocytes but augments deterioration of deformability after in vitro oxidative stress. Clin Hemorheol Microcirc. 40(3): 235-42.
25. Drazen DL, Bilu D, Bilbo SD, Nelson RJ (2001 ) Melatonin enhancement of splenocyte proliferation is attenuated by luzindole, a melatonin receptor antagonist. Am J Physiol Regul Integr Comp Physiol. 280(5): R1476-82.
26. Finocchiaro LM, Glikin GC (1998) Intracellular melatonin distribution in cultured blood cell lines. J Pineal Res. 24(1): 22-34. (Pubitemid 28161018)
27. Flanagan MD, Lin S (1980) Cytochalasins block actin filament elongation by binding to high affinity sites associated with F-actin. J Biol Chem. 255(3): 835-8.
28. Fletcher DA, Mullins RD (2010) Cell mechanics and the cytoskeleton. Nature. 463(7280): 485-92.
29. Frangioni G, Borgioli G, Bianchi S (2003) Melatonin, melanogenesis, and hypoxic stress in the newt, Triturus carnifex. J Exp Zool A Comp Exp Biol. 296(2): 125-36. (Pubitemid 37529096)
30. Glenney JR Jr, Weber K (1981 ) Calcium control of microfilaments: uncoupling of the F-actin-severing and -bundling activity of villin by limited proteolysis in vitro. Proc Natl Acad Sci U S A. 78(5): 2810-4.
31. Grumet M, Lin S (1980) A platelet inhibitor protein with cytochalasin-like activity against actin polymerization in vitro. Cell. 21(2): 439-44. (Pubitemid 10047097)
32. Hardeland R (1999) Melatonin and 5-methoxytryptamine in non-metazoans. Reprod Nutr Dev. 39(3): 399-408.
33. Haslam RJ (1972) Inhibition of blood platelet function by cytochalasins: effects on thrombosthenin and on glucose metabolism. Biochem J. 127(2): 34P.
34. Haut A, Tudhope GR, Cartwright GE, Wintrobe MM (1962) Studies on the osmotic fragility of incubated normal and abnormal erythrocytes. J Clin Invest. 41: 1766-75.
35. Kabsch W, Mannherz HG, Suck D et al. (1990) Atomic structure of the actin: DNase I complex. Nature. 347(6288): 37-44.
36. Kabsch W, Holmes KC (1995) The actin fold. FASEB J. 9(2): 167-74.
37. Kato GJ, McGowan V, Machado RF et al. (2006) Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. Blood. 107(6): 2279-85. (Pubitemid 43345545)
38. Krishan A (1972) Cytochalasin-B: time-lapse cinematographic studies on its effects on cytokinesis. J Cell Biol. 54(3): 657-64.
39. Launay JM, Lamaître BJ, Husson HP et al. (1982) Melatonin synthesis by rabbit platelets. Life Sci. 31(14): 1487-94.
40. Lin S, Spudich JA (1974) Binding of cytochalasin B to a red blood cell membrane protein. Biochem Biophys Res Commun. 61(4): 1471.
41. Lin DC, Lin S (1978) High affinity binding [H3]dihydrocytochalasin B to peripheral membrane proteins related to the control of cell shape in the human red blood cell. J Biol Chem. 253(5): 1415-1.
42. Lin DC, Tobin KD, Grumet M, Lin S (1980) Cytochalasins inhibit nuclei-induced actin polymerization by blocking filament elongation. J Cell Biol. 84(2): 455-60. (Pubitemid 10147879)
43. Mabuchi I (1983) Electron microscopic determination of the actin filament end at which cytochalasin B blocks monomer addition using the acrosomal actin bundle from Horseshoe crab sperm. J Biochem. 94(4): 1349-52.
44. Marchesi VT (1985) The cytoskeletal system of red blood cells. Hosp Pract (Off Ed) 20(11): 113-8, 120, 125-31.
45. Martins E Jr, Fernandes LC, Bartol I et al. (1998) The effect of melatonin chronic treatment upon macrophage and lymphocyte metabolism and function in Walker-256 tumour-bearing rats. J Neuroimmunol. 82(1): 81-9. (Pubitemid 28129339)
46. Matsui DH, Machado-Santelli GM (1997) Alterations in F-actin distribution in cells treated with melatonin. J Pineal Res. 23(4): 169-75. (Pubitemid 127732128)
47. Morera AL, Abreu P (2005) Existence of melatonin in human platelets. J Pineal Res. 39(4): 432-3.
48. Naranjo MC, Guerrero JM, Rubio A et al. (2007) Melatonin biosynthesis in the thymus of humans and rats. 64(6): 781-90.
49. O'Dell BL, Browning JD, Reeves PG (1987) Zinc deficiency increases the osmotic fragility of rat erythrocytes. J Nutr. 117(11): 1883-9. (Pubitemid 18015394)
50. Ortíz-López L, Morales-Mulia S, Ramírez- Rodríguez G, Benítez-King G (2009) ROCK-regulated cytoskeletal dynamics participate in the inhibitory effect of melatonin on cancer cell migration. J Pineal Res. 46(1): 15-21.
51. Pacini N, Borziani F (2009) Action of melatonin on bone marrow depression induced by cyclophosphamide in acute toxicity phase. Neuro Endocrinol Lett. 30(5): 582-91.
52. Pozo D, Delgado M, Fernandez-Santos JM et al. (1997) Expression of the Mel1a-melatonin receptor mRNA in T and B subsets of lymphocytes from rat thymus and spleen. Faseb J. 11(6): 466-73. (Pubitemid 27259988)
53. Ramírez-Rodríguez G, Meza I, Hernández ME et al. (2003) Melatonin induced cyclic modulation of vectorial water transport in kidney-derived MDCK cells. Kidney Int. 63(4): 1356-64. (Pubitemid 36350000)
54. Ramírez-Rodríguez G, Ortiz-López L, Benítez-King G (2007) Melatonin increases stress fibers and focal adhesions in MDCK cells: participation of Rho-associated kinase and protein kinase C. J Pineal Res. 42(2): 180-90.
55. Regodón S, del Prado Míguez M, Jardín I et al. (2009) Melatonin, as an adjuvant-like agent, enhances platelet responsiveness. J Pineal Res. 46(3): 275-85.
56. Reiter RJ, Tan DX, Fuentes-Broto L (2010) Melatonin: a multitasking molecule. Prog Brain Res. 181: 127-51.
57. Rosengarten H, Meller E, Friedhoff AJ (1972) In vitro enzymatic formation of melatonin by human erythrocytes. Res Commun Chem Pathol Pharmacol. 4(2): 457-65.
58. Rossi MT, Scalera G, Di Bella L (1976) Azione mielotropa della melatonina. Boll Soc ltal Biol Sper. Vol. LII, N.18 bis.
59. Rossi MT, Di Bella L (1988) Melatonin in thrombocytogenesis. The pineal gland and cancer, edited by Gupta et al. Brain Research Promotion. 183-94.
60. Shepro D, Belamarich FA, Robblee L, Chao FC (1970) Antimotility effect of cytochalasin B observed in mammalian clot retraction. J Cell Biol. 47(2): 544-547.
61. Szczepanik M. (2007) Melatonin and its influence on immune system. J Physiol Pharmacol. 58 Suppl 6: 115-24.
62. Tan DX, Manchester LC, Reiter RJ et al. (1999) Identification of highly elevated levels of melatonin in bone marrow: its origin and significance. Biochim Biophys Acta. 1472(1-2): 206-14. (Pubitemid 29486531)
63. Tesoriere L, D'Arpa D, Conti S et al. (1999) Melatonin protects human red blood cells from oxidative hemolysis: new insights into the radical-scavenging activity. J Pineal Res. 27(2): 95-105. (Pubitemid 29440989)
64. Tsukita S, Tsukita S, Ishikawa H. (1984) Bidirectional polymerization of G-actin on the human erythrocyte membrane. J Cell Biol. 98(3): 1102-10. (Pubitemid 14166544)
65. Vacas MI, Del Zar MM, Martinuzzo M, Cardinali DP (1992) Binding sites for [3H]-melatonin in human platelets. J Pineal Res. 13(2): 60-5. (Pubitemid 23009576)
66. Varga Z, Panyi G, Péter M Jr et al. (2001) Multiple binding sites for melatonin on Kv1.3. Biophys J. 80(3): 1280-97. (Pubitemid 32182154)
67. White JG, Estensen RD (1971) Influence of cytochalasin B (CB) on platelet aggregation. J Lab Clin Med. 78(5): 849-50.
68. Wilson JE, Schwab DA (1996) Functional interaction of hexokinase with ATP requires participation by both small and large lobes of the enzyme: implications for other proteins using the actin fold as a nucleotide binding motif. FASEB J. 10(7): 799-801. (Pubitemid 26172826)
69. Yau MY, Pang CS, Kravtsov G et al. (2002) 2[125I]Iodomelatonin binding sites in guinea pig platelets. J Pineal Res. 32(2): 97-105. (Pubitemid 34289587)
70. Yerer MB, Yapislar H, Aydogan S et al. (2004) Lipid peroxidation and deformability of red blood cells in experimental sepsis in rats: The protective effects of melatonin. Clin Hemorheol Microcirc. 30(2): 77-82. (Pubitemid 38402420)
71. Yerer MB, Aydogan S (2006) The importance of circadan rhythm alterations in erythrocyte deformability. Clin Hemorheol Microcirc. 35(1-2): 143-7. (Pubitemid 44126491)